Antibody · 폐암 (NSCLC)

28개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved28 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyCurated CoreFDAstaleRocheApproved

atezolizumab (Tecentriq, MPDL3280A)

NSCLC, SCLC, HCC, TNBC, urothelial carcinoma, and others · PD-L1

#PD-L1#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 693Status Approved
AntibodyLimited DatastaleRochePhase 3

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody)

Carcinoma, Non-Squamous Non-Small Cell Lung · PD-L1

#PD-L1#Antibody#Phase3#Popular#monoclonal-antibody+3
Trials 141Status Active
AntibodyCurated CorestaleEli Lilly and CompanyPhase 3

Ramucirumab (Ramucirumab)

Advanced Esophageal Adenocarcinoma; Advanced Gastric Adenocarcinoma · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase3#BioJungboMoa-pick#Popular+5
Trials 117Status Recruiting
AntibodyLimited DatastaleAstraZenecaPhase 3

Durvalumab (MEDI4736, MEDI4736 (Durvalumab))

Non-Small-Cell Lung Carcinoma NSCLC · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase3#Popular#monoclonal-antibody+3
Trials 94Status Active
AntibodyLimited DatastaleAstraZenecaPhase 3

durvalumab (Imfinzi, MEDI4736, MEDI4736 (Durvalumab) + Tremelimumab)

Non-Small-Cell Lung Carcinoma NSCLC · Advanced Solid Malignancies

#AdvancedSolidMalignancies#Antibody#Phase3#Popular#monoclonal-antibody+2
Trials 56Status Recruiting
AntibodyCurated CorestaleJanssenPhase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#BioJungboMoa-pick#Popular+5
Trials 51Status Recruiting
AntibodyLimited DatastaleImmunityBio, Inc.Phase 2

Necitumumab (Necitumumab)

Squamous Cell Carcinoma · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#monoclonal-antibody#SquamousCellCarcinoma+1
Trials 23Status Discontinued
AntibodyLimited DatastalePfizerPhase 1

sasanlimab (sasanlimab)

Carcinoma, Pancreatic Ductal; Colorectal Neoplasms · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase1#monoclonal-antibody#Carcinoma+3
Trials 23Status Discontinued
AntibodyLimited DatastaleJanssen Research & Development,…Phase 2

Cetrelimab (Cetrelimab)

Carcinoma, Non-Small-Cell Lung · Neoplasms

#Neoplasms#Antibody#Phase2#monoclonal-antibody#Carcinoma+2
Trials 20Status Recruiting
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Vibostolimab (Vibostolimab)

Neoplasm Metastasis · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#monoclonal-antibody#NeoplasmMetastasis+1
Trials 19Status Recruiting
AntibodyLimited DatastaleStemcentrxPhase 1

Rovalpituzumab Tesirine (Rovalpituzumab Tesirine)

Small Cell Lung Carcinoma · Small Cell Lung Cancer

#SmallCellLungCancer#Antibody#Phase1#monoclonal-antibody#SmallCellLungCarcinoma+1
Trials 13Status Active
AntibodyLimited DatastaleRochePhase 3

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8 · Lung Non-Small Cell Carcinoma

#LungNon-SmallCellCarcinoma#Antibody#Phase3#monoclonal-antibody#StageIILungCancerAJCCv8+1
Trials 7Status Recruiting
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Boserolimab (Boserolimab)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#monoclonal-antibody#Carcinoma+2
Trials 5Status Recruiting
AntibodyLimited DatastaleThe First Affiliated Hospital o…Phase 2

Adebellizumab (Adebellizumab)

Resectable Lung Non-Small Cell Carcinoma · Resectable Lung Non-Small Cell Carcinoma

#ResectableLungNon-SmallCellCarci#Antibody#Phase2#monoclonal-antibody#The
Trials 3Status Recruiting
AntibodyLimited DatastaleDwight OwenPhase 1

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

Metastatic Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma

#MetastaticLungNon-SmallCellCarci#Antibody#Phase1#monoclonal-antibody#RecurrentLungNon-SmallCellCarcin+1
Trials 2Status Recruiting
AntibodyLimited DatastaleRocheApproved

atezolizumab (Tecentriq, Atezolizumab Injection [Tecentriq])

Hepatocellular Carcinoma · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Approved#monoclonal-antibody#HepatocellularCarcinoma+1
Trials 2Status Active
AntibodyLimited DatastaleRoswell Park Cancer InstitutePhase 1

Nimotuzumab (Nimotuzumab)

EGFR Gene Mutation; Recurrent Non-Small Cell Lung Carcinoma · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#monoclonal-antibody#EGFRGeneMutation+2
Trials 2Status Active
AntibodyLimited DatastaleXencor, Inc.Phase 2

XmAb18087 (XmAb18087)

Merkel Cell Carcinoma; Small Cell Lung Cancer · Merkel Cell Carcinoma

#MerkelCellCarcinoma#Antibody#Phase2#monoclonal-antibody#SmallCellLungCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastaleKymab LimitedPhase 2

Alomfilimab (Alomfilimab)

Squamous Cell Carcinoma of Head and Neck; Non-small Cell Lung Cancer · Squamous Cell Carcinoma of Head and Neck

#SquamousCellCarcinomaofHeadandNe#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancer+1
Trials 1Status Discontinued
AntibodyLimited DatastaleGustave Roussy, Cancer Campus, …Phase 2

atezolizumab (Tecentriq, Anti-PD-L1 antibody atezolizumab)

Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma ) · PD-L1

#PD-L1#Antibody#Phase2#monoclonal-antibody#PatientsWithMetastaticTumoursCol+3
Trials 1Status Active

1 / 2 pages

← PreviousNext →